This bill amends the Congressional Budget and Impoundment Control Act of 1974 to codify a Panel of Health Advisors within the Congressional Budget Office (CBO). The panel will provide technical and functional expertise to improve CBO’s health- and health care–related studies, models, and official cost estimates; meet at least once a year; and deliver an annual report to the House and Senate Budget Committees that the CBO must publish on its website.
The statutory language prescribes the panel’s membership, terms, subject-matter priorities, and two accountability mechanisms: a specified voting threshold for panel recommendations and a required director’s statement describing how CBO used those recommendations. By embedding an external advisory body into CBO’s statutory framework, the bill aims to routinize outside technical input into federal budget scorekeeping on health policy—while leaving implementation details and day-to-day discretion with the CBO Director.
At a Glance
What It Does
The bill creates an internal CBO advisory body—the Panel of Health Advisors—charged with giving expertise on health finance, models, and cost estimates and with producing an annual report of recommendations. The Director of CBO selects priorities for the Panel with Congressional Budget Committee leaders and consults Panel members in meetings.
Who It Affects
Directly affects the Congressional Budget Office’s staff and analysts who produce health-related studies and scores, the House and Senate Budget Committees that receive the Panel’s annual report, and prospective appointees drawn from health finance, actuarial science, providers, and industry. Indirectly affects legislators, federal health programs (Medicare, Medicaid), and stakeholders whose legislation is scored by CBO.
Why It Matters
The change embeds routine external review and a formal reporting channel into CBO’s health work, potentially shaping modeling choices, assumptions, and transparency practices for high-profile budgetary items like Medicare, Medicaid, and federal subsidies. It also creates new appointment and ethics touchpoints that can influence who gets to advise federal scorekeepers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The HEALTH Panel Act turns an advisory practice into statute by creating a 15-member Panel of Health Advisors housed within the Congressional Budget Office. The Panel’s job is to bring outside technical know-how to CBO’s health-related research and to advise on models and cost estimates.
The bill requires at least one meeting per year and an annual report to the Budget Committees, which CBO must post publicly.
Membership is split between congressional appointees and the CBO Director: four congressional leaders—the two Budget Committee chairs and two ranking members—each appoint three members, and the Director appoints three. Appointees serve as special Government employees and are chosen for expertise across a broad set of health fields (finance, actuarial science, delivery systems, drug development, providers, and federal programs).
Terms run three years with staggered starts and a two-term limit.The bill specifies how the Panel should focus its work: it provides recommendations on CBO’s economic and non‑economic health studies, official cost estimates for proposed legislation, modeling techniques, and CBO’s health-related publications such as the Budget and Economic Outlook and insurance coverage projections. The Panel must vote to approve recommendations—those approved by at least nine members are included in the annual report—and the CBO Director must explain in that report how CBO used (or did not use) the recommendations when preparing studies and scores.
The Director also retains authority to set confidentiality agreements and a public disclosure system for potential conflicts of interest.
The Five Things You Need to Know
The Panel will have 15 members: 3 appointed by each of the four Budget Committee leaders (House chair, House ranking member, Senate chair, Senate ranking member) and 3 appointed by the CBO Director.
Members serve as special Government employees under federal ethics law, with terms of 3 years, staggered initially, and a two‑term (six‑year) maximum.
The Panel must meet at least once annually and submit a public annual report; recommendations included in that report must have been approved by at least 9 Panel members.
The CBO Director must include in the annual report a description of how CBO used any Panel recommendations and the extent to which they were integrated into studies and cost estimates; the Director also decides priorities for Panel meetings in consultation with Budget Committee leaders.
The Director may require public conflict-of-interest disclosures from Panel members and can impose confidentiality agreements to protect information provided to CBO for official work products and confidential congressional requests.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Establishes the bill’s popular name: the Healthy Equipping And Lending Technical Help Panel Act (HEALTH Panel Act). This is purely a drafting formality but signals Congressional intent to treat the new advisory structure as a named program within the CBO statutory framework.
Establishes the Panel within CBO
Creates a statutory locus: the Panel is declared to be ‘within the Congressional Budget Office.’ That placement gives the Director direct operational control and ties the Panel’s outputs explicitly to CBO’s institutional mandate of producing budget and economic analysis.
Duties, required report, and priority areas
Lists the Panel’s duties (technical expertise, at least one meeting per year, and an annual report) and identifies the subject-matter priorities the Panel should advise on—non‑economic and economic CBO studies, official cost estimates for health legislation, models and projections, and CBO’s standard health publications. The provision also sets the reporting mechanics: recommendations approved by at least 9 members appear in the report, and the Director must describe how those recommendations were used in CBO’s work.
Membership composition and qualifications
Specifies 15 members with appointments split among congressional leaders and the CBO Director. The text lists areas of expertise to target—health finance, actuarial science, facility management, drug development, payers and providers, and federal programs—while requiring members to serve as special Government employees, thereby triggering federal ethics rules applicable to SGEs.
Terms, leadership, and limits
Sets three-year terms with staggered initial appointments, authorizes the Director to designate a chair and vice chair (after considering Committee recommendations), and limits service to two full terms. Vacancy rules follow the original appointment mechanism and allow members to serve past term expiration until successors are in place.
Table of contents update
Adds the new section number and heading to the Act’s table of contents. This does not change substance but completes the statutory insertion so the Panel appears in CBO’s enabling statute.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- CBO analysts and modelers — gain structured access to outside technical expertise and peer review that can improve assumptions, model design, and credibility of health-related scoring.
- Budget Committee staff — receive a formal, published channel of expert recommendations and a Director’s account of how CBO incorporated that advice, improving transparency for committee deliberations on health legislation.
- Legislators and drafters of health legislation — may get clearer, more technically grounded feedback on how proposals will score and what model assumptions drive cost estimates, reducing surprise changes in fiscal scoring.
Who Bears the Cost
- Congressional Budget Office — absorbs the administrative burden of supporting the Panel (meetings, report drafting, publication, and potential confidentiality regimes) without an explicit funding authorization in the bill.
- Panel appointees — serve as special Government employees subject to federal ethics rules and potential public disclosure requirements, which can limit participation by industry executives or create burdens for private-sector experts.
- Budget Committees and Congress — may face increased political scrutiny and pressure over appointments, and the report-and-response framework could lengthen review cycles for high-profile health proposals, potentially slowing legislative decisionmaking.
Key Issues
The Core Tension
The central dilemma is between improving CBO’s technical grounding on health issues by institutionalizing outside expertise and preserving the nonpartisan, independent posture of federal scorekeeping; creating a formal advisory channel increases technical input and transparency but also opens avenues for political influence, conflicts of interest, and operational burdens that can undermine perceived or actual impartiality.
Two implementation frictions stand out. First, the bill leaves significant discretion to the CBO Director on priorities, chair selection, confidentiality, and how recommendations are integrated.
That preserves CBO’s operational independence but creates ambiguity about how influential the Panel will be in practice. The Director’s required ‘‘description’’ of how recommendations were used is a transparency mechanism, but it is descriptive rather than prescriptive: it does not require CBO to adopt recommendations or to meet a substantive standard when explaining non-adoption.
Second, the appointment split gives congressional leaders direct influence over nine of the 15 seats, raising the risk of politicized selections. The statute mitigates this with the Director’s selection of three members and instructions to appoint chairs ‘‘without regard to political affiliation,’’ but it does not set objective conflict-of-interest limits beyond authorizing public disclosures and confidentiality agreements.
That tension matters because members serve as special Government employees who may have ongoing ties to industry or advocacy groups, and those ties could affect perception of the Panel’s independence.
A final practical issue is resource and scope alignment: the bill expects substantive input on complex modeling and cost estimates but does not appropriate funds or specify staff support. If CBO cannot fund the Panel’s work or lacks the bandwidth to evaluate recommended methodological changes, the Panel’s reports could produce expectations that CBO is unable to meet in practice.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.